LAA Closure for Atrial Fibrillation using Occlusion Device

Congenital and Structural Interventions

H. Sievert

Building Evidence for 3D Printing MAY 2016 ECONOMIC Evaluations of I…

SME

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Georgia Heart Institute

D. Weisman, C. Ellis

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

ACC 2023 Conference Coverage

A. Natale

Stroke Prevention in Atrial Fibrillation

Penn Medicine Heart and Vascular Center

D. Goldberg

Why Interventional Cardiologist Should be on Twitter

Northwell Health Cardiovascular Fellows Course 2018

C. Alraies

Are Office-Based Procedures Safe? Ready for Prime Time?

Comprehensive Arterial and Venous Endovascular Conference (CVC) 2015

R. Zakir

Not Your Grandfather’s Medical School: How the New Mayo Medical Scho…

Cardiovascular Disease Management - 4th Annual Symposium

A Revolutionary Approach to Left Atrial Appendage Closure - LAMINAR …

University of Miami

S. Kar

Atrial Fibrillation: New Treatments

The Texas Heart Institute

J. Cozart

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

Piedmont Heart Institute Napa Valley Cardiology Conference

T. Deering

The Guidelines: Current Recommendations for TAVR, Left Atrial Append…

Cardiology Fiesta 2017

S. Bailey

When Is LAA Closure Device an Option?

Stanford Medicine

C. Liu

LAA Closure: Patient Selection, Imaging and Anti-Thrombotic Therapy

ARCH Advanced Revascularization Symposium

S. Yakubov

Persistent Atrial Fibrillation Ablation: What to Do Beyond PVI and i…

Penn Medicine Heart and Vascular Center

D. Callans

Transcatheter LAA Closure for Stroke Prevention: Current Data and Fu…

Scripps 9th Annual Structural Heart Intervention and Imaging 2020: A Practical Approach

M. Price

What’s the Best Way to Manage Patients with Atrial Fibrillation?

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

J. Hsu